Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Abstract

Noncompetitive blockade of the nicotinic acetylcholine receptor-ion channel complex by an irreversible cholinesterase inhibitor.

K S Rao, Y Aracava, D L Rickett and E X Albuquerque
Journal of Pharmacology and Experimental Therapeutics January 1987, 240 (1) 337-344;
K S Rao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y Aracava
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D L Rickett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E X Albuquerque
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Interactions of O-ethyl S-[2-(diisopropylamino)ethyl]methylphosphonothioate (VX), an irreversible, organophosphorus, anticholinesterase (anti-ChE) agent, with the nicotinic acetylcholine receptor-ion channel complex (AChR) of the frog Rana pipiens were investigated using electrophysiological techniques. At low concentrations (0.1-0.5 microM) of VX, typical effects due to cholinesterase (ChE) inhibition, such as potentiation of indirect muscle twitches as well as increases in the peak amplitude and decay time constant (tau EPC) of end-plate currents (EPC), were observed. At concentrations greater than or equal to 1.0 microM, VX produced opposite effects. The indirectly elicited muscle twitches and EPC peak amplitude were depressed with an IC50 of about 33 microM. tau EPC was reduced, and at a higher concentration of 100 microM, VX split the decays into faster and slower components. Similar results were also obtained with the amplitude and decays of miniature end-plate currents (MEPC). However, although the MEPC peak amplitude and tau MEPC were not decreased to levels below control values, EPC peak amplitude (but not its tau EPC) was markedly depressed beyond the control values, in a concentration-dependent manner. The fact that nerve action potential-evoked events were more affected than the spontaneous MEPCs suggested an interference with the depolarization-evoked release process. Indeed, VX caused a reduction of the quantal content and, in addition, induced a significant increase in the frequency of MEPCs. All these effects, except the anti-ChE activity, were reversible upon wash. The results from both EPC fluctuation analysis and single channel recordings disclosed a concentration-dependent shortening of the channel open times without change in single channel conductance.(ABSTRACT TRUNCATED AT 250 WORDS)

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 240, Issue 1
1 Jan 1987
  • Table of Contents
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Noncompetitive blockade of the nicotinic acetylcholine receptor-ion channel complex by an irreversible cholinesterase inhibitor.
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract

Noncompetitive blockade of the nicotinic acetylcholine receptor-ion channel complex by an irreversible cholinesterase inhibitor.

K S Rao, Y Aracava, D L Rickett and E X Albuquerque
Journal of Pharmacology and Experimental Therapeutics January 1, 1987, 240 (1) 337-344;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Abstract

Noncompetitive blockade of the nicotinic acetylcholine receptor-ion channel complex by an irreversible cholinesterase inhibitor.

K S Rao, Y Aracava, D L Rickett and E X Albuquerque
Journal of Pharmacology and Experimental Therapeutics January 1, 1987, 240 (1) 337-344;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics